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Acceptability of 2-Liter Volume in Filipino Continuous
Ambulatory Peritoneal Dialysis Patients
Romina A. Danguilan, Ronald S. Perez, Mary Joyce M. Berbisco, Leizel P. Evangelista
Objective: To determine whether there is any significant difference in symptoms resulting from the use of the
1.5 L versus the 2.0 L continuous ambulatory peritoneal dialysis (CAPD) bag in patients on regular CAPD.
Methods: Patients were randomized to receive either 1.5 L or 2.0 L fill volumes using a 1.5% dextrose solution,
with the dialysate allowed to dwell for 2 hours. Patients were then asked to answer a questionnaire to determine
if they experienced any discomfort during the dwell period. Symptoms were also analyzed using a score of one
point for every type of discomfort experienced by the patient and 0 if the symptom was absent. The number of
patients in each group who had no discomfort symptoms, discomfort symptom scores between 0 and 5, or
more than five discomfort symptoms was determined.
Results: Sixty patients were enrolled in the study, with 30 patients in each treatment group. The study groups
were comparable in age, sex, primary renal disease, body surface area, height, and weight. They differed in
duration on CAPD before administration of the test. Patients in the 1.5 L group were on CAPD for a shorter
period (median, 5 days) than those in the 2.0 L group (median, 92 days; p = 0.00, Mann-Whitney test). Fourteen
patients (46.7%) in the 1.5 L group and 11 patients (36.7%) in the 2.0 L group experienced discomfort symptoms.
Only three patients (10.0%) in each of the two study groups experienced abdominal pain. Patients were asked
to answer a clinical assessment questionnaire on what type of discomfort they experienced during dwell time.
The proportions of patients with difficulty breathing, abdominal pain, and difficulty sitting were significantly
higher among those in the 1.5 L group than the 2.0 L group. Logistic regression analysis to control for the
effect of the time interval in order to determine whether there was any difference between the groups in the
discomfort experienced showed that there was no significant difference. There was also no significant difference
in symptom score between the two groups.
Conclusion: There was no increase in abdominal discomfort when patients used the 2.0 L dialysis fluid bag
compared to the 1.5 L bag. The hesitancy of patients to use larger volume exchange may be due to patient bias
rather than abdominal discomfort. [Hong Kong J Nephrol 2003;5(2):84–9]
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INTRODUCTION
The Philippines is one of the few remaining countries
in the Asia Pacific region that still predominantly uses
the 1.5 L volume in continuous ambulatory peritoneal
dialysis (CAPD). The Renal Disease Registry of the
Philippines in 2001 showed that of 180 patients on
CAPD, 65% were using 1.5 L bags, 27% were using
1.0 L bags, and only 4% were using 2.0 L bags. Hong
Kong, Singapore and Korea, however, all use
2.0 L bags as standard therapy for the majority of
patients [1–3].
In the Philippines, attempts to convert patients from
the 1.5 L to the 2.0 L bag have been unsuccessful due
to patients’ complaints of fullness, difficulty breathing,
and abdominal discomfort. In addition, despite the cost
savings of about US$86 per month if patients use three
exchanges of 2.0 L versus the current standard therapy
of four exchanges of 1.5 L, this does not seem sufficient
encouragement for patients to use the 2.0 L bags.
In a prospective study of 59 CAPD patients in
Korea, Group 1 patients had gradually increasing fill
volumes from 500 mL to 2.0 L volume exchange up to
13 days, whereas Group 2 patients had 2.0 L volume
exchanges every 6 hours from the day of catheter
implantation. Both groups were advised to take bed rest
during the first 3 days. The occurrence of pericatheter
leaks was equivalent in the two groups. Abdominal
discomfort was noted in only two patients in Group 2.
The study showed no evidence of more short- or long-
term complications in immediate full-volume exchange
compared to the stepwise volume increase [4].
Several studies have examined the tolerability of
randomly sequenced volumes of peritoneal dialysis
(PD) fluid from 1.5 L to 3.0 L. They found that most
patients were unable to identify the exchange volumes
and that 84% of patients reported no discomfort [5,6].
In order to maximize the effective peritoneal surface
area utilized during CAPD, it is recommended that for
patients with a body surface area (BSA) of 1.2 to
1.64 m2, fill volumes should be 1.5 L to 2.0 L, and for
those with a BSA of 1.65 to 1.97 m2, fill volumes should
be 2.0 L to 2.5 L per exchange. It should also be
emphasized that the average body size in the Philippines
is comparable to that in Hong Kong and Singapore,
and thus, most Filipino patients should be able to
tolerate a standard prescription of 2.0 L per exchange.
The use of bigger fill volumes would result in more
efficient clearance of uremic toxins by maximizing the
effective peritoneal surface area and by allowing the
concentration gradient between the peritoneal capillary
blood and dialysis solution to remain greater for a longer
time. Use of larger volumes thus optimizes solute
clearance [7].
This study aimed to determine whether there was
any significant difference in the symptoms of patients
resulting from the use of 1.5 L versus 2.0 L CAPD bags
in patients on regular CAPD.
The tolerability profile of Filipino CAPD patients
to the volume of fluid contained in the abdomen was
determined to establish whether standard-size Filipino
CAPD patients could tolerate the 2.0 L CAPD bag as
standard therapy, thus leading to more efficient
clearance of uremic solutes and more cost savings.
PATIENTS AND METHODS
This was a randomized clinical trial carried out in the
CAPD unit of a tertiary renal disease referral center.
All current CAPD patients who were seen regularly at
the CAPD unit were eligible for inclusion. Eligible
patients were at least 18 years old with a BSA of at
least 1.4 m2, and currently using 1.5 L dialysate fluid
as standard CAPD therapy; they did not complain of
any discomfort and had no catheter-associated leaks.
Patients were excluded if they either encountered
difficulty in the infusion of the CAPD fluid or slow
drain, if they had CAPD peritonitis within 1 month
before the start of the study, or if they had uncontrolled
hypertension or hypotension. Once eligibility was
established, written consent was obtained from the
patient.
Patients were randomized using labels drawn from
a box. They were instructed that they would be infused
with either 1.5 L or 2.0 L of 1.5% dextrose contained
in a CAPD bag. The CAPD bag was covered with a
cloth so that the patient would not be able to read its
volume. A CAPD nurse performed the dialysis
exchange. CAPD was performed at least 2 hours after
a meal. The dialysate fluid was allowed to dwell in the
abdomen for at least 2 hours. After 1.5 hours of dwell,
patients were asked to sit down for 10 minutes, to walk
around for 10 minutes, and to lie down for 10 minutes.
Patients were then asked to answer a questionnaire to
determine any symptoms that they felt during the dwell
period. Only the investigator knew what volume was
infused into the patient.
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Data analysis
The data were encoded, edited and analyzed using SPSS
10.0 (SPSS Inc, Chicago, IL, USA) and Stata 7.0
software (Stata Corporation, College Station, TX,
USA). Univariate analysis included descriptive
statistics of ordinal and continuous variables, such as
age in years, BSA (m2), height (cm), and weight (kg).
The time interval in days between the start of CAPD
and test administration was calculated using the dates
provided in the data collection sheet.
The t test was used to determine statistically
significant differences in mean values between the two
study groups. Levene’s test for equality of variances
was also considered. If the p value associated with the
t value was 0.05 or less, then the variances were
interpreted as not equal. The Mann-Whitney test was
used to compare the median values of variables that
had skewed distribution. For categorical analysis or test
of proportions, the Chi-squared test was considered for
2 = 2 samples. Fisher’s exact test was used where
appropriate. Logistic regression was employed to test
the effect of CAPD fluid volume on patients’ discomfort
during dialysis, adjusting for the effect of the time
interval. The level of significance was set at 5.0%.
RESULTS
A total of 60 patients were enrolled in the study; 30
were assigned to the 1.5 L dialysate fluid group and 30
to the 2.0 L dialysate fluid group. The two groups were
comparable in age (years), sex, primary renal disease,
BSA (m2), height (cm), and weight (kg) (Table 1).
However, they were not comparable in the duration on
CAPD before administration of the test. Patients in the
2.0 L group had been on CAPD for longer (median, 92
days) than patients in the 1.5 L group (median, 5 days).
The Mann-Whitney test showed that the median time
interval was significantly different between the two
study groups (p = 0.000).
Fourteen patients (46.7%) in the 1.5 L group and
11 patients (36.7%) in the 2.0 L group experienced
discomfort symptoms as a result of the fluid infused
into them. More patients in the 2.0 L group (26.7%)
complained of bloatedness than in the 1.5 L group
(10%) (Table 2). Only three patients (10.0%) in each
Table 1. Demographic data of the two study groups.
1.5 L 2.0 L
(N = 30) (N = 30)
Mean age ( SD 45.03 ( 18.2   43.37 ( 9.99 0.662
Sex, n (%) 0.300
Female    19 (63.3)    16 (53.3)
Male    11 (36.7)    14 (46.7)
Primary renal disease, n (%) 0.300
CGN    18 (60.0)    25 (83.3)
DM nephropathy      8 (26.7)      3 (10.0)
HTN nephropathy      3 (10.0)    1 (3.3)
Vasculitis    1 (3.3) 0 (–)
Urate nephropathy 0 (–)    1 (3.3)
Mean BSA ( SD (m2)  1.51 ( 0.16     1.53 ( 0.13 0.545
Mean height ( SD (cm) 157.9 ( 9.7 161.3 ( 7.8 0.134
Mean weight ( SD (kg)   53.2 ( 10.2   53.4 ( 8.9 0.953
Time interval between start of CAPD & test administration
Median (d)   5    92 0.000
Mean ( SD (d)     55.47 ( 117.61     160.13 ( 170.83
SD = standard deviation; CGN = chronic glomerulonephritis; DM = diabetes mellitus; HTN = hypertension; BSA = body surface area;
CAPD = continuous ambulatory peritoneal dialysis.
Factor    p
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Table 4. Comparison of symptom scores between the two study groups.
Volume of CAPD fluid
1.5 L, n 2.0 L, n
0 17 20
0 < score ) 5   8   9
> 5   5   1 0.288
Total 30 30
CAPD = continuous ambulatory peritoneal dialysis.
of the two groups reported abdominal pain. Difficulty
breathing and inguinal pain were reported only by
patients in the 1.5 L group.
Table 3 shows the proportion of patients in each
group who experienced discomfort, as expressed in a
clinical assessment questionnaire on what type of
discomfort they experienced during dwell time. Twelve
patients (40.0%) in the 1.5 L group felt abdominal pain
as against four (13.3%) in the 2.0 L group. More patients
in the 1.5 L group had difficulty breathing (30.0%) and
difficulty sitting (26.7%) during dwell time than
patients in the 2.0 L group (6.7% and 3.3%,
respectively). Fisher’s exact test showed that the
proportion of patients complaining of difficulty
breathing, abdominal pain and difficulty sitting were
significantly different between the two groups
(p < 0.05). The proportion for each type of discomfort
was significantly greater in the 1.5 L group than in the
2.0 L group.
Symptom scores were derived from a 10-item
questionnaire (Table 4). A standard was arbitrarily set
based on a clinical decision. Each of the 10 items had a
Table 2. Complaints of patients who felt discomfort during dialysis (open-ended question).
1.5 L 2.0 L
(N = 30) (N = 30)
Abdominal pain, n (%) 3 (10.0) 3 (10.0) 1.0
Difficulty breathing, n (%) 1 (3.3) 0 (–) 1.0
Bloatedness, n (%) 3 (10.0) 8 (26.7) 0.18
Inguinal pain, n (%) 2 (6.7) 0 (–) 0.49
No answer, n (%) 5 (16.7) 0 (–) 0.05
*Fisher’s exact probability test.
 p*Complaint
Discomfort symptom score    p
Table 3. Comparison of patient complaints between the two study groups by structured clinical assessment.
1.5 L 2.0 L
(N = 30) (N = 30)
Bloatedness, n (%) 9 (30.0) 8 (26.7) 1.00
Difficulty breathing, n (%) 9 (30.0) 2 (6.7) 0.04
Abdominal pain, n (%) 12 (40.0) 4 (13.3) 0.04
Inguinal pain, n (%) 4 (13.3) 2 (6.7) 0.67
Difficulty walking, n (%) 5 (16.7) 3 (10.0) 0.71
Difficulty sitting, n (%) 8 (26.7) 1 (3.3) 0.03
Difficulty lying down, n (%) 5 (16.7) 2 (6.7) 0.42
Numbness, n (%) 5 (16.7) 5 (16.7) 1.00
Back pain, n (%) 5 (16.7) 2 (6.7) 0.42
Shoulder pain, n (%) 6 (20.0) 4 (13.3) 0.73
*Fisher’s exact probability test.
Type of discomfort p*
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score of 1 if the symptom was present and 0 if the
symptom was absent. Symptom scores were further
categorized into three groups: no discomfort symptoms,
discomfort symptom score between 0 and 5, and
discomfort symptom score of more than 5. There was
no significant difference in symptom scores between
the groups.
Logistic regression to determine whether there were
significant differences in the discomfort (difficulty
breathing, abdominal pain, and difficulty sitting)
experienced by patients between the two groups, with
control for the effect of the time since starting CAPD,
showed that there was no significant difference between
the two groups (Table 5).
The 95% confidence interval of each of these
symptoms was wide. Computing for the power for each
symptom, most values were less than 60.0%. The small
power values signify that the wide range of the
confidence interval is mainly due to the small sample
size.
DISCUSSION
This study determined whether the reluctance to use a
larger CAPD exchange volume was due to severe
abdominal discomfort. As pointed out by Sarkar et al,
part of patients’ reluctance to use a larger exchange
volume is their fear of discomfort [5]. This is brought
about by the preconceived idea that a larger exchange
volume will cause more discomfort. To prove their
point, Sarkar et al blinded patients to the infused volume
(2.0 L, 2.5 L, or 3.0 L). The difference in reported
discomfort experienced by these patients was
insignificant. Therefore, all patients, regardless of body
mass, can actually tolerate a large exchange volume.
Patients’ perception might be due, in part, to health
care providers themselves, who might indirectly
Table 5. Regression analyses of the effects of continuous ambulatory peritoneal dialysis (CAPD) exchange volume on difficulty breathing,
abdominal pain, and difficulty sitting.
Odds ratio SE p 95% CI
Difficulty breathing
CAPD volume (1.5 L) 3.09 2.83 0.22 0.51–18.63
Time interval (d) 0.99 0.01 0.19 0.97–1.00
Abdominal pain
CAPD volume (1.5 L) 2.65 1.88 0.17 0.66–10.68
Time interval (d) 0.99 0.004 0.12 0.98–1.00
Difficulty sitting
CAPD volume (1.5 L) 6.88 7.91 0.09 0.72–65.38
Time interval (d) 0.99 0.005 0.32 0.98–1.00
SE = standard error; CI = confidence interval.
transmit their opinions to patients [5]. The lack of
reassurance and support by health professionals and
the explanation of the possible side effects when on a
higher exchange volume might be interpreted by
patients as a lack of confidence of their tolerating larger
volumes.
Based on our data, only one-third of patients
(36.7%) from the 2.0 L group experienced symptoms
of discomfort, compared to half of patients in the
1.5 L group (46.7%), during an exchange session with
a dwell time of 2 hours. This confirmed the finding
that there is no increase in abdominal discomfort when
patients use the 2.0 L dialysis fluid bag. This
study strengthened Sarkar et al’s hypothesis that
the intolerability of patients to using larger volume
exchanges originates more from patients’ bias
rather than in actual discomfort from the volume of
fluid used [5].
It is possible that more patients in the 1.5 L group
experienced more symptoms of discomfort because of
their  shorter  durat ion on CAPD before the
administration of the test (median, 5 days) compared
to patients in the 2.0 L group (median, 92 days). The
longer time on CAPD in the 2.0 L group could have
acclimatized patients’ abdomens to accommodate the
increased volume. A previous study, however, found
no short- or long-term complications in patients who
received 2.0 L volumes immediately after catheter
placement or those in whom the volume was gradually
increased from catheter implantation for up to 2 weeks
[4]. The discrepancy in randomization may be partly
explained by the fact that many patients in our clinic
have been on peritoneal dialysis for a long period. The
results of this study are important because they show
that the symptoms of discomfort experienced by
patients were similar, despite the differences in volume.
The questionnaire was structured in such a way that
the patient was first given the freedom to describe what
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he felt during the dwell time, and this was followed by
a structured questionnaire. This technique was used in
order to detect discomfort in different ways by asking
different types of questions. It also provided a double
check of whether the patient truly felt the symptoms.
This is illustrated in Table 4, which shows that 17 of
30 patients did not have complaints of discomfort in
the 1.5 L group. On the other hand, it was inferred from
our data that 16 of 30 did not have discomfort. On
further review, it was revealed that one patient in the
1.5 L group who had claimed a sense of bloatedness
when he answered an open-ended question denied this
when asked to check the symptoms described on the
questionnaire. Peculiarly, this was also observed in the
2.0 L group, where one patient also claimed that he felt
a sense of bloatedness, but later denied all the symptoms
enumerated on the structured clinical assessment. The
value in asking different types of questions is to increase
the chances of detecting a symptom by eliciting it in
various ways.
One limitation of the study is that it only addressed
the problem of subjective tolerance. Objective measures
such as intraperitoneal pressure and effect of gastric
emptying could have been very informative and could
have been correlated with subjective discomfort
symptoms. However,  these procedures were
unavailable in our unit. Secondly, the study did not
measure the severity of each symptom. The
questionnaire asked for mostly “Yes” or “No” answers.
Patients were asked at the end of the questionnaire if
any discomfort was enough to cause them to discontinue
CAPD. None of the patients felt that they would
discontinue therapy, and therefore, it may be surmised
that symptoms were only mild.
The role of health care professionals is very
important in convincing patients to shift to the 2.0 L
fill volume. Patients will follow the recommendations
of their health care providers if they are reassured that
using a larger exchange volume will not be detrimental
to their health and that it will achieve more efficient
clearance of uremic toxins. Renal physicians and nurses
should be confident of the tolerability of Filipino
patients to the 2.0 L dialysate bag.
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